MiniMed (MMED) Equity Average (2026)
MiniMed (MMED) posted Equity Average of $3.6 billion for Q3 2026, up 2.23% quarter-over-quarter from $3.5 billion in Q2 2026, and up 5.3% YoY from $3.4 billion in Q3 2025.
Powered by 
Analysis
MiniMed (MMED) Equity Average (2026) Analysis & Trends
MiniMed (MMED) has 2 years of Equity Average data on file, last reported at $3.6 billion in Q3 2026.
- For the quarter ending Q3 2026, Equity Average rose 5.3% year-over-year to $3.6 billion; the trailing twelve-month figure through Jul 2026 stood at $3.6 billion (up 5.3% YoY), and the FY2026 full-year result was $3.5 billion, up 2.4% from the prior year.
- Equity Average was $3.6 billion for Q3 2026 at MiniMed, up from $3.5 billion in the prior quarter.
- In the past five years, Equity Average ranged from a high of $3.6 billion in Q3 2026 to a low of $3.4 billion in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 52.23 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 17.95 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 50.46 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 23.48 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 25.64 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 10.53 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 21.86 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 2.79 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 7.21 Bn |
| 10 | MiniMed | 6.37 Bn | 6.17 Bn | 465.00 Mn | 3.62 Bn |